TP53 and cancer: Our method suggests that EP300 plays a role in the p53 pathway, which is strengthened by previous studies that show its interaction with TP53. Furthermore, EP300 aberrations have been observed in other types of cancer, but it has not been specifically linked to the progression of glioblastoma.